跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Asmamed Plus - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Asmamed Plus
Approved
STANDARD
Asmamed Plus
Azarias Pharmaceutical Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
80c7114500beae69
Company
Azarias Pharmaceutical Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
80c7114500beae69
Drug Approval Philippines Name
Asmamed Plus
Product Name
Asmamed Plus
Registration Number
DRP-5519
Brand Name
Asmamed Plus
Generic Name
Guaifenesin + Salbutamol (as sulfate)
Dosage Form
Syrup
Dosage Strength
50 mg/ 1 mg per 5 mL
Manufacturer
Azarias Pharmaceutical Laboratories, Inc.
Issuance Date
27 September 2024
Expiry Date
22 September 2029
Pharmacologic Category
Expectorant/ Anti-asthma
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
80c7114500beae69
Type
Standard
Back to Philippines FDA Approvals